edp-514
Showing 1 - 4 of 4
Chronic Hepatitis B Virus Infection Trial in Auckland (EDP-721, Placebo (Part 1), EDP-721 (Part 2))
Terminated
- Chronic Hepatitis B Virus Infection
- EDP-721
- +4 more
-
Auckland, New ZealandNew Zealand Clinical Research Ltd
Feb 2, 2022
Hepatitis B Trial in Lenexa (EDP-514, Itraconazole, Carbamazepin)
Completed
- Hepatitis B
- EDP-514
- +3 more
-
Lenexa, KansasPharmaceutical Research Association
Aug 13, 2021
Chronic HBV Infection Trial in Hong Kong, Taiwan (EDP-514, Placebo)
Completed
- Chronic HBV Infection
- EDP-514
- Placebo
-
Hong Kong, Hong Kong
- +9 more
Jan 6, 2022
Chronic HBV Infection Trial in Canada, United States (EDP-514, Placebo)
Completed
- Chronic HBV Infection
- EDP-514
- Placebo
-
Coronado, California
- +14 more
Jan 6, 2022